Colorado BioScience Association links life science leaders to legislators at annual Capitol event
Health-Tech Innovators Advocate For Colorado’s Advanced Industries Grants
DENVER, Colo. – A culture of collaboration has made Colorado the #1 Health Innovation ecosystem in the United States today.
Organizations like Prime Health, the Colorado Bioscience Association (CBSA), Innosphere and the Office of Economic Development and International Trade (OEDIT), are working on behalf of the ecosystem to support programs and funding that drive innovation and acceleration commercialization.
One of the qualities that make Colorado unique for entrepreneurs is the publicly supported advanced industries grants and tax credits run by OEDIT. These programs encourage private investors to provide funding for local companies with high growth potential.
Colorado BioScience Association welcomes nationally recognized thought leaders to address state’s medical device industry
DENVER – Colorado BioScience Association (CBSA) highlights how changes in federal policy, major shifts in healthcare
will impact the state’s thriving medical device industry as part of the annual CBSA Medical Device Symposium. Medical device sector policy discussions
will cover the opportunities presented by proposed regulatory relief, corporate tax reform and the possible full repeal of the medical device excise
tax under the new administration.
Boomtown Accelerator forges relationship with Colorado BioScience Association
BOULDER, Colo — Jan. 10, 2017 — Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited
to announce that they have established a relationship with the Colorado BioScience Association (CBSA).
21st Century Cures: What's Next for Colorado?
DENVER, Colo. – The biomedical research industry supports more than seven million jobs and contributes $69 billion to the U.S. GDP. In 2015, with a budget
of over $30 billion, the National Institutes of Health (NIH) funded more than 300,000 scientists to support groundbreaking research around the globe.
Colorado BioScience Association Recaps Growth Year for State’s Life Science Sector
For Immediate Release: December 15, 2016
Colorado BioScience Association Celebrates Year of Medical and Business Breakthroughs at Annual Awards Dinner
Silvergate Pharmaceuticals Named Company of the Year, BiO2 Medical Honored as Rising Star
Medical Discovery And Fighting Disease Are Non-Partisan
For policymakers and candidates willing to embrace public policies that help support the development of new treatments and cures, a unique proposition
exists: Colorado voters will reward those who make medical discovery a key part of their platform.
Venaxis Announces Acquisition of BiOptix
CASTLE ROCK, Colo., Sept. 13, 2016 /PRNewswire/ -- Venaxis®, Inc. (Nasdaq: APPY),
announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary
Enhanced Surface Plasmon Resonance ("E‑SPR") technology platform for the detection of molecular interactions. The technology was developed in conjunction
with Dr. John 'Jan' Hall, Adjoint Professor, JILA (University of Colorado), who shared the Nobel Prize for Physics in 2005.
CBSA Forum Highlights Impact of Life Science on Colorado’s Innovation Economy
Inaugural Colorado Life Science Innovation Forum showcases the state’s pioneering spirit, entrepreneurial courage and patient-first focus, offering robust discussions and networking opportunities Continue Reading
- CU Boulder Study: Federally-Funded Laboratories and Institutions Have a $2.6 Billion Annual Impact in Colorado
- New Study Shows Biodesix’s VeriStrat Changes Treatment Decisions for Lung Cancer Patients; Reduces Over-Treatment at End of Life
- Flagship Bioscience: Is PD-L1 Harmonization on the Horizon?
- InDevR Launches Next-Generation Software for the Cypher One™ System
- ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update